Inlyta Prices, Coupons and Patient Assistance Programs
Inlyta is available as a brand name drug only, a generic version is not yet available. See generic Inlyta availability.
Inlyta (axitinib) is a member of the multikinase inhibitors drug class and is commonly used for Renal Cell Carcinoma.
Inlyta prices
The cost for Inlyta oral tablet 1 mg is around $18,727 for a supply of 180 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Inlyta price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Oral Tablet
Quantity | Per unit | Price |
---|---|---|
180 | $104.04 | $18,727.37 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Quantity | Per unit | Price |
---|---|---|
60 | $312.12 | $18,727.37 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Inlyta Coupons and Rebates
Inlyta offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Inlyta Pfizer Oncology Together Co-Pay Savings Program (oral products): Eligible commercially insured patients may pay as little as $0 per prescription with savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.
- Applies to:
- Inlyta
- Number of uses:
- 12 times within calendar year
- Expires
- December 31, 2023
Form more information phone: 877-744-5675 or Visit website
Inlyta Pfizer Oncology Together Co-Pay Savings Program Rebate (oral products): Eligible commercially insured patients may submit a request for a rebate in connection with this offer if their pharmacy does not participate in the program; for additional information contact the program at 877-744-5675.
- Applies to:
- Inlyta
- Number of uses:
- One rebate per prescription fill
- Expires
- December 31, 2023
Form more information phone: 877-744-5675 or Visit website
Patient Assistance Programs for Inlyta
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: HealthWell Foundation Copay Program
Elligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Inlyta (axitinib) Tablet
More information please phone: 800-675-8416 Visit Website
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Inlyta (axitinib) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Pfizer Oncology Together
Elligibility requirements:- Contact program for details.
- Not disclosed
- Varies
- The patient must also be under treatment from a US doctor.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Inlyta (axitinib) Tablet
More information please phone: 877-744-5675 Visit Website
Provider: Pfizer RxPathways
Elligibility requirements:- Contact program for details.
- Varies
- FDA-approved diagnosis
- Must be residing in the US or US territory
- Co-payment assistance, and patient assistance programs are available for eligible patients. Call for most recent medications as the list is subject to change.
- Inlyta (axitinib) Tablet
More information please phone: 844-989-7284 Visit Website
More about Inlyta (axitinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1)
- Drug images
- En español
- Drug class: multikinase inhibitors
- FDA approval history